Skip to main content
. 2017 Jan 18;32(1):271–276. doi: 10.1080/14756366.2016.1247062

Figure 1.

Figure 1.

Structure of quinazolines A, thienopyrimidines B and benzopyrrolopyridines C as EGFR inhibitors.